BIOMAT Database Logo BIOMAT Database Logo

Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule. 2007

Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D003840 Deoxycholic Acid A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Deoxycholate,Desoxycholic Acid,Kybella,Choleic Acid,Deoxycholic Acid, 12beta-Isomer,Deoxycholic Acid, 3beta-Isomer,Deoxycholic Acid, 5alpha-Isomer,Deoxycholic Acid, Disodium Salt,Deoxycholic Acid, Magnesium (2:1) Salt,Deoxycholic Acid, Monoammonium Salt,Deoxycholic Acid, Monopotassium Salt,Deoxycholic Acid, Monosodium Salt,Deoxycholic Acid, Sodium Salt, 12beta-Isomer,Dihydroxycholanoic Acid,Lagodeoxycholic Acid,Sodium Deoxycholate,12beta-Isomer Deoxycholic Acid,3beta-Isomer Deoxycholic Acid,5alpha-Isomer Deoxycholic Acid,Deoxycholate, Sodium,Deoxycholic Acid, 12beta Isomer,Deoxycholic Acid, 3beta Isomer,Deoxycholic Acid, 5alpha Isomer
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Is 24 hours infusion of amphotericin B deoxycholate as good as liposomal amphotericin B?
August 2002, Swiss medical weekly,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
June 2005, Pharmacotherapy,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Minimizing nephrotoxicity using continuous infusion of deoxycholate amphotericin B.
October 2014, The Pediatric infectious disease journal,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.
January 2013, PloS one,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial.
March 2001, BMJ (Clinical research ed.),
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Amphotericin B deoxycholate administered by continuous infusion: does the dosage make a difference?
April 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex.
January 2000, Scandinavian journal of infectious diseases,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function.
November 2015, The Cochrane database of systematic reviews,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study.
April 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Philipp Altmannsberger, and Ernst Holler, and Reinhard Andreesen, and Stefan W Krause
Continuous infusion of amphotericin B deoxycholate for the treatment of life-threatening Candida infections.
October 2013, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!